“…These early "preclinical" memory changes are more likely to occur in those with a genetic susceptibility marker for AD, the apolipoprotein E (APOE) ε4 allele [11,37], than in those without this risk factor. In parallel with these findings, structural [32,44] and functional [4,6,15,20,34,42] neuroimaging alterations are more evident in non-demented elderly with the ε4 allele than in those without this allele type.…”